| Detected | Trial | Change |
|---|---|---|
| 2026-05-28 | NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-28 | NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or… |
Trial sites reduced: 186 -> 158 locations |
| 2026-05-28 | NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or… |
date change Primary completion pushed: 2026-05-14 -> 2026-06-15 |
| 2026-05-28 | NCT06346392 AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or… |
date change Completion pushed: 2026-09-14 -> 2026-10-14 |
| 2026-05-28 | NCT07431281 Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in… |
Trial sites expanded: 258 -> 269 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07431281 | Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in… | Gastric Cancer | Recruiting |
| NCT06346392 | AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or… | Gastric Cancer | Active, Not Recruiting |
| Phase 2 | |||
| NCT06219941 | AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 | Gastric Cancer | Recruiting |
| NCT05702229 | Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic… | Gastric Cancer | Recruiting |
| NCT07069712 | A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With… | Gastroesophageal Adenocarcinoma | Recruiting |
| NCT07143604 | A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+… | Gastric Cancer | Active, Not Recruiting |